Your browser (Internet Explorer 7 or lower) is out of date. It has known security flaws and may not display all features of this and other websites. Learn how to update your browser.

X

Navigate / search

Partnerships for Development of Clinically Useful Diagnostics for Antimicrobial-Resistant Bacteria (R01)

Key Dates: 

Posted Date: June 1, 2017

Open Date (Earliest Submission Date): September 4, 2017

Letter of Intent Due Date(s): September 4, 2017

Application Due Date(s): October 4, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date . Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Da(s): Not Applicable

Scientific Merit Review: February 2018

Advisory Council Review: May 2018

Earliest Start Date: June 2018

Purpose: 

The objective of this initiative is to support milestone-driven projects focused on the development of clinically informative diagnostic platforms that identify select antimicrobial-resistant bacterial pathogens and determine associated antimicrobial sensitivity and/or resistance. Applications must include a Product Development Strategy and demonstrate substantive investment by at least one industrial participant. 

Expiration Date: 
Thursday, October 5, 2017
Announcement Number: 
RFA-AI-17-014